A

Abeona Therapeutics
D

ABEO

5.88000
USD
0.01
(0.17%)
مغلق
حجم التداول
13,108
الربح لكل سهم
-1
العائد الربحي
-
P/E
-9
حجم السوق
300,801,608
أصول ذات صلة
C
CRBP
-0.15750
(-2.03%)
7.60000 USD
P
PLX
0.02500
(1.66%)
1.53500 USD
S
SGMO
0.00200
(0.38%)
0.53200 USD
S
SLDB
0.14500
(2.97%)
5.02000 USD
S
SYBX
-0.06000
(-4.76%)
1.20000 USD
V
VXRT
-0.01110
(-2.53%)
0.42750 USD
المزيد
الأخبار المقالات

العنوان: Abeona Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.